NCCS

Ad Industry Recognizes New Benchmark For Low Fraud, As IVT Rate Held Under 1% In Tag Certified Channels In US For Third Straight Year

Retrieved on: 
Thursday, November 2, 2023
Benchmark, NCCS, Education, Sport, CTV, SSPS, Supply-side platform, MFA, Fraud, Filtration, Advertising, MRC, Research, Crime, TAG, IVT, Ecosystem, California Community College Athletic Association, AI, Success, Interview, Financial adviser, Pharmaceutical industry, Cryptocurrency

WASHINGTON, Nov. 2, 2023 /PRNewswire/ -- The digital advertising industry has reached consensus on a single metric to measure its success in achieving a predictable, consistent, and low fraud rate, according to the 2023 TAG US Fraud Benchmark Study. [https://www.tagtoday.net/pressreleases/ad-industry-recognizes-new-benchm...

Key Points: 
  • "Now the ad industry has reached consensus on a unified metric to validate the success of our own all-stars at fighting fraud.
  • Interviews from this year's US Fraud Benchmark Study confirm that our industry has reached consensus on a sub-1% IVT rate as the appropriate benchmark to validate the effectiveness of a company's anti-fraud efforts.
  • The IVT rate in Non-Certified Channels (NCCs), where only a single entity was certified, was 46% higher at 1.19%.
  • In addition, The 614 Group conducted a series of industry expert interviews with executives at agencies on background for qualitative perspectives.

Hitachi's Proton Therapy System Now in Use at National Cancer Centre Singapore

Retrieved on: 
Wednesday, October 4, 2023
Proton, Education, Proton therapy, Neoplasm, Respiration, Cancer, Light, Quality of life, Rehabilitation, Research, Carbon, Noetics, Motion, Hospital, SingHealth, Patient, NCCS, Medical imaging

TOKYO, Oct 4, 2023 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501, "Hitachi") and Hitachi Asia Ltd. announced today that it has delivered to National Cancer Centre Singapore ("NCCS") a proton therapy system, with which NCCS has completed the first patient treatment as of 11 August 2023.

Key Points: 
  • TOKYO, Oct 4, 2023 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501, "Hitachi") and Hitachi Asia Ltd. announced today that it has delivered to National Cancer Centre Singapore ("NCCS") a proton therapy system, with which NCCS has completed the first patient treatment as of 11 August 2023.
  • This marks Hitachi's first proton therapy system to start treatment in Southeast Asia.
  • NCCS is a leading national and regional tertiary cancer centre with specialists who are experts in treating cancer.
  • Hitachi provides products and services of particle therapy systems with higher performance and added value, which can be found in leading hospitals around the world, ranging from proton therapy system, heavy ion therapy system to hybrid system combined with the capabilities of proton and carbon therapy.

Application Programming Interface (API) Security Market worth $3,034 million by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, July 6, 2023
Cloud, JSON, CSA, Web API security, Defender, ISO, Classification, Internet of things, API, WS02, OWASP, Research, MEA, ACSC, Prisma, OVA, OAuth, Organization, Cloud computing, Red Hat, WAAS, Growth, WAF, SME, NCCS, Speciality chemicals, Risk management, Airline, Medical device, Fine chemical, Apigee, Theorem, Application, Palo Alto Networks

The hybrid deployment mode experiences the highest CAGR, offering organizations a comprehensive solution for their API security needs.

Key Points: 
  • The hybrid deployment mode experiences the highest CAGR, offering organizations a comprehensive solution for their API security needs.
  • The hybrid deployment mode also brings flexibility in managing API security, enabling organizations to choose the most suitable gateway types for different environments.
  • By driving the demand for such solutions, SMEs play a significant role in shaping the API security market.
  • In January 2021, Palo Alto Networks (US) launched Prisma Cloud 2.0, introducing the Web Application and API Security (WAAS) module.

Application Programming Interface (API) Security Market worth $3,034 million by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, July 6, 2023
Cloud, JSON, CSA, Web API security, Defender, ISO, Classification, Internet of things, API, WS02, OWASP, Research, MEA, ACSC, Prisma, OVA, OAuth, Organization, Cloud computing, Red Hat, WAAS, Growth, WAF, SME, NCCS, Speciality chemicals, Risk management, Airline, Medical device, Fine chemical, Apigee, Theorem, Application, Palo Alto Networks

The hybrid deployment mode experiences the highest CAGR, offering organizations a comprehensive solution for their API security needs.

Key Points: 
  • The hybrid deployment mode experiences the highest CAGR, offering organizations a comprehensive solution for their API security needs.
  • The hybrid deployment mode also brings flexibility in managing API security, enabling organizations to choose the most suitable gateway types for different environments.
  • By driving the demand for such solutions, SMEs play a significant role in shaping the API security market.
  • In January 2021, Palo Alto Networks (US) launched Prisma Cloud 2.0, introducing the Web Application and API Security (WAAS) module.

New Castle Community Schools Taps PowerSchool to Support College, Career, and Life Readiness Program

Retrieved on: 
Monday, May 15, 2023
Primary, Secondary, Education, Technology, Software, Other Education, Internet, Cloud, Assistant superintendent, Teacher, New Castle Community School Corporation, Curriculum, Research, Student, Applicant tracking system, Knowledge, PK-12, NYSE, NCCS, Management, Nursing, Naviance, Pearson Education

PowerSchool (NYSE: PWSC) today announced New Castle Community Schools (NCCS) in New Castle, Indiana selected PowerSchool Naviance , a core component of the PowerSchool Workforce Development Cloud , to support its college, career, and life readiness (CCLR) program.

Key Points: 
  • PowerSchool (NYSE: PWSC) today announced New Castle Community Schools (NCCS) in New Castle, Indiana selected PowerSchool Naviance , a core component of the PowerSchool Workforce Development Cloud , to support its college, career, and life readiness (CCLR) program.
  • “Through our district’s positive experience using PowerSchool SIS, selecting Naviance to support our college and career readiness program was an easy decision,” said Adam McDaniel, Assistant Superintendent, New Castle Community School Corporation.
  • New Castle Community School Corporation (New Castle Community Schools) is a public school corporation located in New Castle, Indiana.
  • New Castle Community Schools offers a PK-12 curriculum across eight total schools – including one high school, one middle school, and six elementary schools.

Medidata Patient Insights Leader Alicia Staley Honored by National Coalition for Cancer Survivorship

Retrieved on: 
Tuesday, November 22, 2022
Other Health, Managed Care, General Health, Philanthropy, Oncology, Data Management, Consumer, Technology, Foundation, Women, Other Philanthropy, Health, Cloud, NCCS, Ellen, Clinical trial, Breast cancer, National Coalition for Syrian Revolutionary and Opposition Forces, National Coalition for Cancer Survivorship, Patient engagement in Canada, Multimedia, Social media, Staley, Cancer, Caregiver, SOLIDWORKS, Dassault Group, Life, D.C, Research, CATIA, SIMULIA, DELMIA, Diagnosis, Learning, Strathcona County, Euronext Paris, 3D, Patient, Pharmaceutical industry, GEOVIA, ENOVIA, Compass, Medidata Solutions, BIOVIA

Medidata , a Dassault Systmes company, announced that vice president for Patient Engagement and leader of its Patient Insights Board Alicia Staley has been honored with the Ellen L. Stovall Award for patient advocacy from the National Coalition for Cancer Survivorship (NCCS).

Key Points: 
  • Medidata , a Dassault Systmes company, announced that vice president for Patient Engagement and leader of its Patient Insights Board Alicia Staley has been honored with the Ellen L. Stovall Award for patient advocacy from the National Coalition for Cancer Survivorship (NCCS).
  • View the full release here: https://www.businesswire.com/news/home/20221122005590/en/
    NCCS CEO Shelley Fuld Nasso (left), Medidata vice president for Patient Engagement Alicia Staley Photo: Leslie E. Kossoff/LK Photos
    Alicias influence as a leader reaches a national and, in fact, a global audience.
  • Alicia is one of the most effective community builders, a collaborator, and a facilitator within groups of people seeking to improve care for cancer patients and their families, said Anne Marie Mercurio, a patient advocate who sits on the Medidata Patient Insights Board.
  • Alicia is one of the most respected voices and creative influences in increasing patient engagement in clinical trials, said Anthony Costello, Medidata Patient Cloud CEO.

Tessa Therapeutics to Host Scientific Session on CD30 CAR-T targeting of CD30+ Lymphomas at the SDCT-REMEDIS Cell Therapy Conference 2022

Retrieved on: 
Monday, June 13, 2022
SingHealth, Company, Conference, Marketing, CD30, Lymphatic system, European Medicines Agency, TT11, PRIME, Hematological Cancer Research Investment and Education Act, Cancer, Therapy, FDA, GLOBE, Private Securities Litigation Reform Act, Trial of the century, Duke–NUS Medical School, Hodgkin lymphoma, Immunotherapy, Associate professor, Safety, NCCS, Pharmaceutical industry, Medical device

SINGAPORE, June 13, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the company will host a scientific session during the SDCT-REMEDIS Cell Therapy Conference 2022 being held virtually from June 23-24, 2022.

Key Points: 
  • SINGAPORE, June 13, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the company will host a scientific session during the SDCT-REMEDIS Cell Therapy Conference 2022 being held virtually from June 23-24, 2022.
  • Tessas scientific session will focus on CD30 CAR-T targeting of CD30+ lymphomas and will feature a presentation from Dr. Ivan Horak, Chief Medical Officer and Chief Scientific Officer of Tessa Therapeutics.
  • Tessa is currently advancing two clinical programs leveraging distinct CD30 CAR-T technologies for the treatment of CD30+ lymphomas.
  • Additionally, Tessa is developing an allogenic off-the-shelf CD30-CAR EBVST cell therapy TT11X targeting relapsed or refractory CD30-positive lymphomas.

Aker Carbon Capture and SINTEF Expand Collaboration to Develop Next-Generation CCUS Technology

Retrieved on: 
Thursday, March 31, 2022
Carbon, CCS, SINTEF, Risk, International Energy Agency, SOLVIT, University, CO2, Research, IPCC, Medicine, CEO, NCCS, Aker, Industry, Knowledge, Goal, Norwegian University of Science and Technology, Climate, United Nations, Science, Solution, NTNU, Paris Agreement, Paris, IEA, Partnership, Renewable energy, Technology

OSLO, Norway, March 31, 2022 /PRNewswire/ -- Aker Carbon Capture and SINTEF have entered into a strategic collaboration agreement, with the goal of further developing carbon capture utilization and storage (CCUS) technology to reduce CO2 emissions from industry and energy solutions.

Key Points: 
  • OSLO, Norway, March 31, 2022 /PRNewswire/ -- Aker Carbon Capture and SINTEF have entered into a strategic collaboration agreement, with the goal of further developing carbon capture utilization and storage (CCUS) technology to reduce CO2 emissions from industry and energy solutions.
  • Establishing a common framework for collaboration will remove barriers and bureaucracy, thereby enabling SINTEF and Aker Carbon Capture to collaborate quickly and efficiently.
  • Aker Carbon Capture is today a leading provider of a proprietary, amine-based carbon capture technology, which is being deployed in the Norwegian full-scale CCUS project, Langskip (Longship).
  • Aker and Aker Carbon Capture have worked with CCUS for two decades, and its proprietary carbon-capture technology offers a unique, environmentally friendly solution for removing CO2 emissions.

Aker Carbon Capture and SINTEF Expand Collaboration to Develop Next-Generation CCUS Technology

Retrieved on: 
Thursday, March 31, 2022
Carbon, CCS, SINTEF, Risk, International Energy Agency, SOLVIT, University, CO2, Research, IPCC, Medicine, CEO, NCCS, Aker, Industry, Knowledge, Goal, Norwegian University of Science and Technology, Climate, United Nations, Science, Solution, NTNU, Paris Agreement, Paris, IEA, Partnership, Renewable energy, Technology

OSLO, Norway, March 31, 2022 /PRNewswire/ -- Aker Carbon Capture and SINTEF have entered into a strategic collaboration agreement, with the goal of further developing carbon capture utilization and storage (CCUS) technology to reduce CO2 emissions from industry and energy solutions.

Key Points: 
  • OSLO, Norway, March 31, 2022 /PRNewswire/ -- Aker Carbon Capture and SINTEF have entered into a strategic collaboration agreement, with the goal of further developing carbon capture utilization and storage (CCUS) technology to reduce CO2 emissions from industry and energy solutions.
  • Establishing a common framework for collaboration will remove barriers and bureaucracy, thereby enabling SINTEF and Aker Carbon Capture to collaborate quickly and efficiently.
  • Aker Carbon Capture is today a leading provider of a proprietary, amine-based carbon capture technology, which is being deployed in the Norwegian full-scale CCUS project, Langskip (Longship).
  • Aker and Aker Carbon Capture have worked with CCUS for two decades, and its proprietary carbon-capture technology offers a unique, environmentally friendly solution for removing CO2 emissions.

The National Children's Cancer Society recognized among leading charities with triple star rating from Charity Navigator

Retrieved on: 
Wednesday, March 16, 2022
Twitter, National Children's Cancer Society, NCCS, Organization, Accreditation, Charity Navigator, Candid (organization), Strathcona County, Leadership, Organic, Cancer, Instagram, Growth, Management, Facebook

ST. LOUIS, March 16, 2022 /PRNewswire-PRWeb/ -- The National Children's Cancer Society (NCCS) was recently awarded a triple star rating from Charity Navigator, America's premier independent charity evaluator.

Key Points: 
  • ST. LOUIS, March 16, 2022 /PRNewswire-PRWeb/ -- The National Children's Cancer Society (NCCS) was recently awarded a triple star rating from Charity Navigator, America's premier independent charity evaluator.
  • Philanthropic supporters look to Charity Navigator to ensure charitable organizations are stewarding resources responsibly and performing services for their constituents with the highest integrity.
  • In addition to the star rating system, Charity Navigator also provides deeper insights for inquiring givers into a philanthropic organization's administration of resources.
  • The NCCS has received a triple star rating from Charity Navigator, recognized as a Better Business Bureau Accredited Charity and has earned a GuideStar Platinum Seal of Transparency.